Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
DNA vaccination wikipedia , lookup
Immune system wikipedia , lookup
Adaptive immune system wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Molecular mimicry wikipedia , lookup
REVIEWS Emerging inflammasome effector mechanisms Mohamed Lamkanfi Abstract | Caspase 1 activation by inflammasome complexes in response to pathogenassociated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) induces the maturation and secretion of the pro-inflammatory cytokines interleukin-1β (IL-1β) and IL-18. Recent reports have begun to identify additional inflammasome effector mechanisms that proceed independently of IL-1β and IL-18. These include the induction of pyroptotic cell death, the restriction of bacterial replication, the activation of lipid metabolic pathways for cell repair and the secretion of DAMPs and leaderless cytokines. These non-canonical functions of caspase 1 illustrate the diverse mechanisms by which inflammasomes might contribute to innate immunity, repair responses and host defence. Cryopyrinopathies A spectrum of hereditary autoinflammatory diseases that are caused by mutations in the gene encoding NLR family, pyrin domaincontaining 3 (NLRP3) that trigger continuous activation of the NLRP3 inflammasome. Based on the severity and spectrum of the symptoms — which can include urticarial skin rashes, prolonged episodes of fever, sensorineural hearing loss, headaches, cognitive deficits and renal amyloidosis — these diseases are classified as familial cold autoinflammatory syndrome, Muckle–Wells syndrome or chronic infantile neurological cutaneous articular syndrome. Department of Biochemistry, Ghent University, and VIB Department of Medical Protein Research, Albert Baertsoenkaai 3, B‑9000 Ghent, Belgium. e‑mail: Mohamed.Lamkanfi@ VIB‑UGent.be doi:10.1038/nri2936 Inflammasomes (BOX 1) are emerging as key regulators of the innate immune response, and the activity of these multiprotein complexes has been linked to inflamma‑ tory bowel diseases1–5, vitiligo6, gouty arthritis7, type 1 and type 2 diabetes8,9, and less common autoinflamma‑ tory disorders that are collectively referred to as cryopyrinopathies10,11. Inflammasome complexes are thought to be assembled around members of the NOD-like receptor (NLR) or HIN‑200 protein families 12 (FIG. 1). These receptors are thought to detect microbial pathogenassociated molecular patterns (PAMPs) and endogenous damage-associated molecular patterns (DAMPs) in intra‑ cellular compartments, similar to the role of mammalian Toll‑like receptors (TLRs) at the cell surface and within endosomes13. Although it is incompletely understood how NLRs detect microbial ligands and DAMPs14,15, it is evident that inflammasome assembly results in the activation of caspase 1 (BOX 2). This evolutionarily con‑ served cysteine protease is mainly known for its role in the maturation of the pro‑inflammatory cytokines interleukin‑1β (IL‑1β) and IL‑18 (ReFs 16–19). IL‑1β and IL‑18 are related cytokines that are pro‑ duced as cytosolic precursors and usually require caspase 1‑mediated cleavage for full activation and secretion16–19. However, additional proteases, including caspase 8, myeloblastin (also known as proteinase 3) and granzyme A, have been shown to convert pro‑IL‑1β into a biologically active cytokine in several established mouse models of human disease20–23. This indicates that caspase 1 is not always required for the maturation of IL‑1β, and such redundancy in controlling IL‑1β matura‑ tion might safeguard the host immune response against viral and bacterial pathogens that target caspase 1 activa‑ tion in inflammasomes24. Indeed, IL‑1β and IL‑18 were recognized early on for their ability to cause a wide variety of biological effects associated with infection, inflamma‑ tion and autoimmunity 25. IL‑1β regulates systemic and local responses to infection, injury and immunological challenge by generating fever, activating lymphocytes and promoting leukocyte transmigration into sites of injury or infection25. Although IL‑18 lacks the pyrogenic activity of IL‑1β, it induces interferon‑γ (IFNγ) production by activated T cells and natural killer cells in the presence of IL‑12, thereby contributing to T helper 1 (TH1) cell polarization25,26. In the absence of IL‑12, IL‑18 can pro‑ mote TH2 cell responses through the production of TH2 cell cytokines such as IL‑4, IL‑5 and IL‑10 (ReFs 26–28). More recently, IL‑18 has also been implicated in driving TH17 cell responses because it synergizes with IL‑23 to induce IL‑17 production by already committed TH17 cells29,30. Thus, IL‑1β and IL‑18 are important inflammasome effector molecules, as illustrated by the marked response to therapy with IL‑1 inhibitors found in patients with cryopyrinopathies, who have increased inflammasome activation31,32. However, not all inflammasome functions can be abrogated by neutralization of IL‑1β and IL‑18. For exam‑ ple, caspase 1‑deficient mice are resistant to lipopoly‑ saccharide (LPS)‑induced shock, whereas mice lacking both IL‑1β and IL‑18 are susceptible33. Moreover, a recent study showed that IL‑1β and IL‑18 are not required for caspase 1‑mediated clearance of several bacterial patho‑ gens (namely, modified Salmonella enterica subsp. enterica serovar Typhimurium strains that constitutively express NATuRe RevIewS | Immunology voLuMe 11 | MARcH 2011 | 213 © 2011 Macmillan Publishers Limited. All rights reserved REVIEWS Box 1 | Inflammasomes Inflammasomes are intracellular multiprotein complexes that mediate the proximity-induced autoactivation of caspase 1. Inflammasome-mediated caspase 1 activation has been shown to occur in macrophages, dendritic cells, epithelial cells and possibly other cell types during bacterial, viral, fungal and parasitic infections. Inflammasomes are activated in response to stimulation with damage-associated molecular patterns (DAMPs), such as uric acid and ATP, and upon exposure to crystalline substances, such as monosodium urate, silica and asbestos particles12,24. The molecular composition of inflammasome complexes is stimulus dependent, with certain members of the NOD-like receptor (NLR) and HIN-200 receptor families functioning as the activating platform in these complexes. Genetic studies in mice indicate the existence of at least four types of inflammasome (FIG. 1). Three of these contain NLR proteins, namely NLR family, pyrin domain-containing 1B (NLRP1B), NLR family, CARD-containing 4 (NLRC4) and NLRP3. The fourth type of inflammasome contains the HIN-200 protein absent in melanoma 2 (AIM2)12. The bipartite adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD; also known as PYCARD) probably has a key role in inflammasome assembly and caspase 1 activation by bridging the interaction between NLRs or HIN-200 proteins and caspase 1, although the precise role of ASC in the activation of the NLRP1B and NLRC4 inflammasomes is debated. NLRP1B and NLRC4 contain a caspase recruitment domain (CARD) at their carboxyl and amino termini, respectively (unlike AIM2 and NLRP3, which have a pyrin domain) and can therefore interact directly with caspase 1 when overexpressed, without requiring ASC. However, evidence of a role for ASC in the activation of the endogenous NLRC4 inflammasome is provided by the observation that robust caspase 1 activation and the production of interleukin-1β (IL-1β) and IL-18 are markedly decreased in ASC-deficient macrophages infected with viral or bacterial pathogens, or exposed to a variety of DAMPs and crystalline substances50,63,88. flagellin, Legionella pneumophila and Burkholderia thailandensis)34. Similarly, caspase 1‑deficient mice are more susceptible to infection with Francisella tularensis than mice lacking both IL‑1β and IL‑18 (ReF. 35), and this indicates that additional caspase 1‑dependent mecha‑ nisms might contribute to the control of infection. In this regard, several recent publications have begun to characterize a range of new inflammasome functions and effector molecules that seem to operate independently of IL‑1β and IL‑18. In this article, I review these emerg‑ ing non‑canonical inflammasome effector mechanisms and attempt to illustrate how they might contribute to immune responses. Proximity-induced autoactivation A process in which two or more initiator caspases are brought sufficiently close to induce their autocatalytic activation. This process is thought to occur in large cytosolic protein complexes to which caspase zymogens are recruited by means of homotypic interactions between the caspase recruitment domain (CARD) or death effector domain (DeD) motifs in their pro-domains and several bipartite adaptor molecules. Unconventional protein secretion Secretory proteins usually contain amino‑terminal or internal signal peptides that target them to the translo‑ cation apparatus of the endoplasmic reticulum (eR)36,37. From the eR lumen, such proteins are transported to the Golgi apparatus and then to the extracellular space in Golgi‑derived secretory vesicles that fuse with the plasma membrane37. This pathway of protein export is known as the ‘eR–Golgi’ or ‘classical’ secretory pathway. However, cytoplasmic and nuclear proteins that lack an eR‑targeting signal peptide can exit cells through eR‑ and Golgi‑independent pathways38. For example, mature IL‑1β was shown to be secreted independently of the eR and the Golgi apparatus more than 20 years ago39. The number of proteins that have been shown to be released by unconventional protein secretion has grown to more than 20, including fibroblast growth factor 2 (FGF2), the lectins galectin 1 and galectin 3, and possibly the DAMP high‑mobility group box 1 (HMGB1)38. After their release into the extracellular space, these effectors can enhance inflammatory, cell survival and repair responses through activation of cell surface receptors, such as FGF recep‑ tor 1, the IL‑1 and IL‑18 receptors and the receptor for advanced glycation end‑products (RAGe). Although the molecular mechanism by which IL‑1β, IL‑18 and other proteins that lack signal peptides are secreted remains obscure, several models have been proposed to explain the release of such ‘leaderless pro‑ teins’ in microvesicles that are shed from the plasma membrane, or in secretory lysosomes or exosomes38. Interestingly, adherent monocytes from caspase 1‑ deficient mice and peritoneal macrophages from mice lacking two inflammasome components — namely, NLR family, pyrin domain‑containing 3 (NLRP3) and apoptosis‑associated speck‑like protein containing a cARD (ASc; also known as PYcARD) — not only failed to secrete IL‑1β and IL‑18 after LPS stimulation16,18,19,40, but were also partially defective in the secretion of the leaderless cytokine IL‑1α17,40. unlike IL‑1β and IL‑18, IL‑1α does not undergo caspase 1‑mediated cleavage26. This might indicate that caspase 1 modulates IL‑1α secretion indirectly by regulating the secretory path‑ way of this cytokine, and may point to a broader role for caspase 1 in regulating unconventional protein secretion. Indeed, pharmacological inhibition, RNA interference (RNAi)‑mediated downregulation and targeted deletion of caspase 1 were all recently shown to block the secre‑ tion of IL‑1β, IL‑1α and FGF2 by macrophages, uvA‑ irradiated fibroblasts and uvB‑irradiated keratinocytes, respectively 41. In addition, caspase 1 activation by either the NLRP3 inflammasome or the NLR family, cARD‑ containing 4 (NLRc4) inflammasome was required for secretion of the nuclear DAMP HMGB1 from activated and infected macrophages33. Because the enzymatic activity of caspase 1 is required for the secretion of each of these leaderless proteins33,41, caspase 1 might medi‑ ate the proteolytic activation of a secretion apparatus of unknown identity. In this context, the small GTPase RAB39A was recently characterized as a caspase 1 sub‑ strate that is involved in the secretion of IL‑1β from LPS‑activated human THP‑1 monocytes42. However, it remains to be determined how caspase 1‑mediated cleav‑ age affects RAB39A function and whether RAB39A has a role in the secretion of additional leaderless proteins. An alternative mechanism by which caspase 1 might promote the release of leaderless proteins such as HMGB1 involves the induction of a specialized caspase 1‑mediated cell death programme in activated immune cells, which is often referred to as pyroptosis (see below). elucidation of the mechanism awaits the characterization of the molecular components mediating caspase 1‑dependent unconventional protein secretion and pyroptosis. Pyroptosis Most caspases (BOX 2) — caspases 2, 3 and 6–10 — are implicated in the induction and execution of apopto‑ sis43,44. This form of programmed cell death is respon‑ sible for organ shaping during embryonic development and for preserving homeostasis in adult organisms. Typical morphological features of apoptosis include plasma membrane blebbing, condensation of the nucleus, 214 | MARcH 2011 | voLuMe 11 www.nature.com/reviews/immunol © 2011 Macmillan Publishers Limited. All rights reserved REVIEWS $CPVJTCEKU NGVJCNVQZKP 56[RJKOWTKWO 2CGTWIKPQUC .RPGWOQRJKNC 5ƓGZPGTK 78KTTCFKCVKQP /KETQDKCN2#/2U 'PFQIGPQWU&#/2U %T[UVCNU r+QPȯWZ! r4GCEVKXGQZ[IGP URGEKGU! ! r.[UQUQOCN %[VQUQNKE FU&0# 0.42 0.42 #+/ #+/ 2;& 2;& 2;& 2;& %#4& 0.4% ! 2;& ! 2;& 0.42+$ %#4& %#4& 0.4% 0.42+$ %#4& RTQVGCUGU! .44U &0#XKTWUGU (VWNCTGPUKU .OQPQE[VQIGPGU %#4& %#4& %#4& %#4& #5% %#4& #EVKXG ECURCUG %#4& 2TQECURCUG Figure 1 | Inflammasomes: composition and stimuli. The NOD-like receptor (NLR) proteins NLR family, pyrin domain-containing 1B (NLRP1B), NLR family, CARD-containing 4 (NLRC4) and NLRP3, and the HIN-200 protein absent in melanoma 2 (AIM2) assemble inflammasomes in a stimulus-specific manner12. NLRP1B recognizes the cytosolic presence of the Bacillus anthracis lethal toxin64. The NLRC4 inflammasome is assembled after detection of bacterial flagellin or the basal body rod component of the bacterial type III and type IV secretion systems of Salmonella enterica subsp. enterica serovar Typhimurium, Pseudomonas aeruginosa, Legionella pneumophila and Shigella flexneri12,58,62. NLRP3 is activated when macrophages are exposed to UV irradiation, microbial pathogenassociated molecular patterns (PAMPs), endogenous damage-associated molecular patterns (DAMPs) such as ATP, or crystals such as monosodium urate, silica and asbestos. Recognition of these PAMPs, DAMPs and crystals is thought to involve the detection of a common secondary messenger, such as K+ fluxes, reactive oxygen species or lysosomal proteases14,15. By contrast, AIM2 directly binds double-stranded DNA (dsDNA) in the cytosol to induce caspase 1 activation in cells infected with Francisella tularensis, Listeria monocytogenes or DNA viruses such as cytomegalovirus and vaccinia virus68–70,72–74. The adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD; also known as PYCARD) is probably required for the full activation of all inflammasome complexes, although its role in the NLRP1B and NLRC4 inflammasomes is still debated45. CARD, caspase recruitment domain; LRR, leucine-rich repeat. PYD, pyrin domain. DNA fragmentation and general shrinkage of the cell volume45. Apoptotic cells usually fail to elicit inflam‑ matory responses because the cytoplasmic content is shielded from the extracellular environment by packag‑ ing in ‘apoptotic bodies’ (FIG. 2). These apoptotic bodies are membrane‑bound cell fragments that are rapidly phagocytosed in vivo by neighbouring cells and resident phagocytes46,47. The integrity of the envelope surround‑ ing apoptotic bodies is usually preserved until after they have been engulfed by professional antigen‑presenting cells or neighbouring cells to prevent accidental spilling of the intracellular content into the extracellular milieu47. Apoptotic cells can also prevent the accidental induction of inflammation by inactivating the immunostimulatory activity of the DAMP HMGB1 through the oxidation of residue cys106 (ReF. 48). Finally, the uptake of apoptotic bodies by macrophages and dendritic cells was recently proposed to actively suppress antigen presentation and the secretion of inflammatory cytokines by these cells49. unlike most caspases, caspase 1 is not involved in the induction of apoptosis. Instead, caspase 1 activation in neurons, macrophages and dendritic cells drives a spe‑ cialized form of cell death known as pyroptosis34,50–53. caspase 1‑dependent cell death was first reported to occur in macrophages infected with Shigella flexneri, the causative agent of bacillary dysentery 54,55. Pyroptosis was subsequently observed in macrophages and dendritic cells infected with the facultative intracellular pathogens S. Typhimurium, Pseudomonas aeruginosa and L. pneumophila45,56,57. each of these pathogens induces caspase 1 activation through the NLRc4 inflammasome (FIG. 1). These pathogens are recognized when bacterial flagel‑ lin is transferred through specialized bacterial type III and type IV secretion systems into the host cell cytosol or upon detection of the basal body rod component of the S. flexneri or P. aeruginosa type III secretion appara‑ tus58–63. The induction of pyroptosis is not restricted to the NLRc4 inflammasome, as Bacillus anthracis infec‑ tion induces the pyroptotic cell death of mouse macro‑ phages through the NLRP1B inflammasome64,65. This occurs when the anthrax metalloprotease lethal factor gains access to the cytosol of susceptible macrophages64. Notably, lethal factor‑induced pyroptosis was shown to confer resistance to infection with B. anthracis spores in vivo65, highlighting the importance of pyroptosis for host defence against pathogens. The pyroptotic cell death of macrophages infected with Staphylococcus aureus requires activation of the NLRP3 inflammasome66,67. Although the precise mechanism is still debated, acti‑ vation of this inflammasome could proceed through several mutually non‑exclusive mechanisms, including K+ efflux, the generation of reactive oxygen species, lyso‑ somal destabilization and the translocation of microbial ligands into the host cytosol14,15. Finally, infections with the bacterial pathogens Listeria monocytogenes and F. tularensis induce pyroptosis upon their recognition in the host cell cytosol by the absent in melanoma 2 (AIM2) inflammasome68–74. The role of caspase 1 in the immune response to F. tularensis, the causative agent of tularaemia, is illustrated by the observation that caspase 1‑deficient mice have increased susceptibility to infection with this pathogen75. Notably, mice lacking the canonical inflammasome substrates IL‑1β and IL‑18 are less susceptible to infection with F. tularensis than caspase 1‑deficient mice 35, and this indicates that additional caspase 1‑dependent mechanisms, such as pyroptosis, might make an important contribution to the control of F. tularensis infection. Indeed, although caspase 1 activity is required for pyroptosis51,76, this form of cell death proceeds independently of IL‑1β and IL‑18 (ReF. 56). A recent study established the cru‑ cial in vivo role of pyroptosis in clearing a modified NATuRe RevIewS | Immunology voLuMe 11 | MARcH 2011 | 215 © 2011 Macmillan Publishers Limited. All rights reserved REVIEWS Box 2 | Caspases Caspases are an evolutionarily conserved family of metazoan cysteine proteases with 11 representatives in humans: caspases 1–10 and caspase 14. Caspases cleave various cellular substrates after aspartic acid residues and have essential roles in apoptosis, inflammation, cell proliferation and cell differentiation89. For example, caspase 3mediated cleavage of mammalian STE20-like kinase 1 (MST1; also known as STK4) was shown to be crucial for skeletal muscle differentiation, and caspase 8-mediated cleavage of the long splice variant of cellular FLICE-like inhibitory protein (cFLIPL) regulates the balance between apoptosis induction and nuclear factor-κB (NF-κB)-driven T cell proliferation90. All caspases are synthesized as zymogens consisting of an amino-terminal pro-domain of variable length and a carboxy-terminal protease domain. Caspases can be subdivided according to the length of their pro-domain (see the figure). Initiator caspases (such as caspases 1 and 8) have large pro-domains containing homotypic protein–protein interaction motifs of the death domain superfamily, specifically either a caspase recruitment domain (CARD) or a death effector domain (DED). These interaction motifs allow the recruitment of pro-caspases into multiprotein complexes (such as the inflammasomes) by homotypic interactions with adaptor molecules such as ASC (apoptosis-associated speck-like protein containing a CARD; also known as PYCARD). Within these complexes, pro-caspases undergo the conformational changes and/or autoprocessing required for their activation91. By contrast, the effector caspases (caspases 3, 6, 7 and 14) have short pro-domains of only a few amino acids and they lack any homotypic interaction motifs. These caspases require proteolytic maturation by the initiator caspases or other proteases to achieve maximum enzymatic activity. Unlike the ‘true’ caspases listed above, human caspase 12 is devoid of enzymatic activity because crucial catalytic residues have been mutated. In addition, most people express a truncated form of caspase 12 that resembles the human CARD-only proteins CARD17 (also known as INCA), CARD18 (also known as ICEBERG) and CARD16 (also known as COP or pseudo-ICE)92. #OKPQ VGTOKPWU +PKVKCVQT ECURCUGU %CTDQZ[N VGTOKPWU 2TQFQOCKP 2TQVGCUGFQOCKP %CURCUGUCPF %#4& %CURCUGFQOCKP %CURCUGUCPF &'& %CURCUGFQOCKP 'ȭGEVQT ECURCUGU %CURCUGUCPF NOD-like receptor (NLR). The human NLR family comprises 22 members. They share a domain organization that usually includes an amino-terminal caspase recruitment domain (CARD) or pyrin domain (PYD), followed by an intermediary nucleotide-binding oligomerization domain (NOD) and carboxy-terminal leucine-rich repeat motifs. NLRs are thought to survey the host cytosol and intracellular compartments for pathogenand damage-associated molecular patterns to activate signalling pathways that contribute to the host innate immune response. %CURCUGFQOCKP S. Typhimurium strain that constitutively expressed 0CVWTG4GXKGYU^+OOWPQNQI[ bacterial flagellin34. The pyroptotic cell death of infected macrophages exposed intracellular bacteria to extracel‑ lular immune surveillance and allowed their destruction by neutrophils. Pyroptosis also conferred protection against the bacterial pathogens L. pneumophila and B. thailandensis, which establishes this inflammasome effector mechanism as a crucial component of host defence against intracellular bacterial pathogens34. Although the molecular mechanisms controlling pyroptosis are still poorly defined, this cell death mode differs morphologically from apoptosis in that pores with a diameter of 1–2 nm appear in the plasma membrane of pyroptotic cells at early time points52. The resulting ion fluxes could explain some of the hallmarks of pyroptotic cells, including cytoplasmic swelling, osmotic lysis and the release of the intracellular content into the extracel‑ lular milieu77 (FIG. 2). In addition to eliminating infected immune cells, this process can enhance innate and adap‑ tive immune responses by exposing microbial antigens to surveillance by the immune system. Together with the fact that caspase 1 activation is linked with the produc‑ tion of mature IL‑1β and IL‑18 and the release of leader‑ less cytokines and DAMPs (such as HMGB1 and S100 proteins), these characteristics are thought to render pyroptosis (and associated inflammasome functions) an inherently pro‑inflammatory cell death mode. Despite the different immunological outcomes of apoptosis and pyroptosis (FIG. 2), apoptotic and pyrop‑ totic cells share several prominent morphological and biochemical features. Nuclear condensation and oligo‑ nucleosomal DNA fragmentation are observed in both cell death modes19,46,51,52,76. Moreover, the DNA damage sensor poly(ADP‑ribose) polymerase 1 (PARP1) is proc‑ essed into an 89 kDa fragment during both apoptosis and pyroptosis46,78. under homeostatic conditions, PARP1 participates in genomic DNA repair and DNA replica‑ tion by catalysing the synthesis of poly(ADP‑ribose) in a process that consumes NAD+ and the ATP energy stores of the cell. Thus, cleavage of PARP1 during both apop‑ tosis and pyroptosis indicates that PARP1 inactivation might be a general strategy used by cells undergoing pro‑ grammed cell death, possibly to preserve energy stores in order to allow for proper dismantling of the cell. Finally, maturation of caspase 3 and caspase 7 is observed during both apoptosis and pyroptosis51,78,79, although pyroptosis‑ associated DNA fragmentation, PARP1 processing and plasma membrane permeabilization are not affected in macrophages lacking either of these executioner caspases51,55,78. This might not come as a complete surprise given that caspase 3 and caspase 7 are partially redundant and that deletion of both caspases was necessary for pro‑ tection against apoptosis80. Nevertheless, S. Typhimurium has been shown to induce pyroptosis in macrophages lacking both caspase 3 and caspase 7 (ReF. 45), and this confirms that these executioner caspases are not neces‑ sary for pyroptosis. Thus, although apoptosis and pyrop‑ tosis share the morphological and biochemical features described above (FIG. 2), the signalling pathways involved are distinct. Despite recent progress in characterizing the molecular features of pyroptotic cell death and its role in host defence against bacterial pathogens, much remains to be learned about the signalling mechanism by which caspase 1 induces pyroptosis. Inhibition of glycolysis In an attempt to identify new caspase 1 substrates that could explain the phenotype of pyroptotic cells, a caspase 1 digestome analysis was carried out, and this identified several crucial enzymes of bioenergetic pathways as potential caspase 1 targets81. Biochemical studies confirmed that the glycolysis enzymes fructose‑ bisphosphate aldolase, glyceraldehyde‑3‑phosphate dehy‑ drogenase, α‑enolase and pyruvate kinase can be cleaved by recombinant caspase 1. These enzymes operate in a metabolic pathway that replenishes cellular ATP energy stores through the conversion of glucose to pyruvate. caspase 1‑mediated processing of glyceraldehyde‑3‑ phosphate dehydrogenase inhibited its enzymatic activ‑ ity 81, and this indicated that caspase 1 might decrease the metabolic rate of infected cells. To address whether caspase 1‑mediated processing of these metabolic enzymes occurred during infection, peritoneal macro‑ phages of wild‑type and caspase 1‑deficient mice were infected with S. Typhimurium. As expected, aldolase was 216 | MARcH 2011 | voLuMe 11 www.nature.com/reviews/immunol © 2011 Macmillan Publishers Limited. All rights reserved REVIEWS 2[TQRVQUKU Pathogen-associated molecular pattern (PAMP). A conserved pathogen molecule that is usually essential for microbial survival, and that contains either nucleic acid structures that are unique to microorganisms or cell wall components (such as lipopolysaccharide and flagellin) that are not found in mammalian cells. PAMPs are ligands for receptors of the host innate immune system. Damage-associated molecular pattern (DAMP). A molecule that is produced or released from host cells upon cellular stress, damage or non-physiological cell death. DAMPs are also referred to as ‘alarmins’ and are thought to be responsible for the initiation and perpetuation of inflammatory responses and tissue repair under non-infectious (sterile) conditions. examples include high-mobility group box 1 (HMGB1), ATP, uric acid and heat-shock proteins. Unconventional protein secretion The secretion of cytoplasmic and nuclear proteins into the extracellular space through an incompletely understood mechanism that does not require the translocation apparatus of the classical endoplasmic reticulum (eR)–Golgi secretion pathway. Proteins that are secreted through this route include interleukin-1α (IL-1α), IL-1β, IL-18, fibroblast growth factor 2, galectin 1, galectin 3 and possibly high-mobility group box 1. Pyroptosis A specialized form of programmed cell death that requires caspase 1 activity. It is characterized by cytoplasmic swelling, early plasma membrane rupture, nuclear condensation and internucleosomal DNA fragmentation. The cytoplasmic content is released into the extracellular space, and this is thought to augment inflammatory and repair responses. Pyroptosis occurs in myeloid cells infected with pathogenic bacteria, and it might affect cells of the central nervous system and the cardiovascular system under ischaemic conditions. #RQRVQUKU /GODTCPG TWRVWTG /GODTCPG UYGNNKPI /GODTCPG XGUKENGHQTOCVKQP 2TGUGTXCVKQP QHOGODTCPG KPVGITKV[ %CURCUGCPF CEVKXCVKQP &0# HTCIOGPVCVKQP 0WENGCT EQPFGPUCVKQP +.β 4GNGCUGQH KPVTCEGNNWNCT EQPVGPVU %CURCUGCPF CEVKXCVKQP %[VQUQNKE UYGNNKPI &0# HTCIOGPVCVKQP */)$ #RQRVQVKEDQF[ HQTOCVKQP %[VQUQNKE UJTKPMCIG 0WENGCT EQPFGPUCVKQP 2#42ENGCXCIG 2#42ENGCXCIG +. 2TQKPȯCOOCVQT[ EGNNFGCVJ +OOWPQNQIKECNN[ UKNGPVEGNNFGCVJ Figure 2 | main features of pyroptosis. The molecular mechanisms underlying pyroptosis are still poorly defined. Morphologically, pyroptotic cells are characterized by the early loss of plasma membrane integrity77, and this is accompanied 0CVWTG4GXKGYU^+OOWPQNQI[ by the shedding of membrane vesicles93. Pyroptotic and apoptotic cells share several prominent features (shown in blue boxes), including nuclear condensation and internucleosomal DNA fragmentation, cleavage of the DNA damage repair enzyme poly(ADP-ribose) polymerase 1 (PARP1) and activation of the executioner caspases caspase 3 and caspase 7 (ReF. 45). However, the volume of the cytoplasmic compartment of pyroptotic cells increases, whereas apoptosis is characterized by general shrinkage of the cell volume. Together with the role of caspase 1 in cytokine maturation and unconventional protein secretion, the release of the cytoplasmic content into the extracellular milieu during pyroptosis is thought to render this form of cell death inherently pro-inflammatory45. By contrast, apoptosis is usually considered to be immunologically silent because the cytoplasmic content is packaged in apoptotic bodies and these membrane-bound cell fragments are rapidly phagocytosed in vivo by neighbouring cells and resident phagocytes47. HMGB1, high mobility group box 1; IL, interleukin. processed in infected wild‑type macrophages, but not in those lacking caspase 1 (ReF. 81). concurrently, the rate of glycolysis in the caspase 1‑deficient cells was markedly higher, further supporting an inhibitory role for caspase 1 in the regulation of glycolysis. Because myeloid cells are highly dependent on glycolysis for ATP production82, caspase 1‑mediated inactivation of glycolysis enzymes might restrict intracellular pathogen replication by quickly depleting energy sources and by preparing infected host cells to undergo pyroptosis. However, it remains to be determined whether and to what extent caspase 1‑ mediated inactivation of glycolysis enzymes contributes to protection against bacterial pathogenicity in vivo. Cell survival Another mechanism by which caspase 1 might protect host cells is by repairing the damage caused by bacte‑ rial pore‑forming toxins that are released by pathogenic bacteria83. The pores formed by these toxins can range significantly in diameter, depending on the nature of the toxin. For example, S. aureus α‑toxin and Aeromonas hydrophila aerolysin typically produce holes in the host cell membrane with a diameter of only 2 nm, whereas Streptococcus pneumoniae and L. monocytogenes pro‑ duce toxins that can create perforations of up to 50 nm in diameter 84. consequently, the latter toxins allow trans‑ location of large proteins across the plasma membrane, whereas S. aureus α‑toxin and A. hydrophila aerolysin only render the plasma membrane permeable to small inorganic ions84. Nevertheless, depending on the concen‑ tration of these toxins and the targeted cell type, the dam‑ age elicited by these toxins can range from irreparable cell destruction to temporal perforations that can quickly be resealed by the host cell’s dedicated repair machinery. Repairing bacterial toxin‑induced damage to the plasma membrane requires the activation of lipid bio‑ genesis pathways, the molecular machinery of which is controlled by two transcription factors known as sterol regulatory element‑binding protein 1 (SReBP1) and SReBP2 (ReF. 84). Interestingly, activation of SReBP1 and SReBP2 is controlled by the NLRP3 and NLRc4 inflammasomes in fibroblasts that have been intoxicated with S. aureus α‑toxin or A. hydrophila aerolysin, or infected with live Aeromonas trota bacteria83. This path‑ way is thought to promote host cell survival because inhi‑ bition or transcriptional downregulation of SReBP1 and SReBP2 enhanced cell death responses83. Inflammasome‑ induced activation of SReBPs is thought to be indirect, but the caspase 1 substrates that drive this pathway remain to be found. It would be interesting to determine whether caspase 1 activates SReBPs in macrophages infected with live A. hydrophila, because these bacteria were recently shown to activate caspase 1 through the NLRP3, but not the NLRc4, inflammasome85. This might reveal differential signalling mechanisms induced by the three A. hydrophila cytotoxins85. NATuRe RevIewS | Immunology voLuMe 11 | MARcH 2011 | 217 © 2011 Macmillan Publishers Limited. All rights reserved REVIEWS Glycolysis A metabolic pathway that generates the cellular high-energy store ATP by oxidizing glucose to pyruvate. In eukaryotic cells, pyruvate is further oxidized into CO2 and H2O in a process known as ‘aerobic respiration’. This results in a net yield of 36–38 molecules of ATP per metabolized molecule of glucose. Autophagosome A double-membrane-bound vesicle that is used by eukaryotic cells to target protein aggregates, damaged organelles and invading microorganisms for digestion by lysosomal hydrolases. This catabolic process allows recycling of cellular components and is thought to contribute to cell death, cell survival during starvation, cellular differentiation and host defence against infectious agents. #EVKXG ECURCUG 5GETGVKQPQTTGNGCUGQH NGCFGTNGUUE[VQMKPGU CPF&#/2U #EVKXCVKQP QH54'$2U 5GETGVKQPQH ITQYVJHCEVQTU .KRKF OGODTCPG DKQIGPGUKU +PȯCOOCVKQP the NLRP3 and NLRc4 inflammasomes in inducing proteolytic maturation of caspase 7 in activated immune cells that were exposed to ATP and nigericin or infected with live S. Typhimurium51. In contrast to caspase 7, the activation of caspase 3 was not affected in caspase 1‑ deficient macrophages51, and this indicates that the activation of caspase 3 and caspase 7 is differentially reg‑ ulated during inflammation. These observations identi‑ fied an alternative mechanism by which inflammasomes might control bacterial infections. Indeed, caspase 7 activation downstream of the NLRc4 inflammasome was subsequently reported in macrophages infected with L. pneumophila 79. Moreover, caspase 7‑deficient macrophages are less capable of restricting intracellular L. pneumophila replication, possibly owing to defects in the fusion of bacteria‑containing phagosomes with lysosomes and the delayed induction of macrophage cell death79. Importantly, caspase 1 and caspase 7 regu‑ late L. pneumophila growth in the lungs of orally infected mice61,79, demonstrating the importance of this inflamma‑ some effector pathway in host defence against this bac‑ terial pathogen. However, it remains to be determined %#4& Two of at least six specialized secretion systems by which Gram-negative pathogens can deliver virulence factors into eukaryotic host cells. Pathogenic bacteria such as Shigella, Salmonella, Yersinia, Chlamydia and Pseudomonas spp. all make use of a type III secretion system to infect host cells and to modulate signalling pathways. By contrast, pathogens such as Helicobacter pylori, Legionella pneumophila and Bordetella pertussis make use of a type IV secretion system for the horizontal transfer of plasmid DNA containing antibiotic resistance genes and to inject effector proteins into eukaryotic host cells. Caspase 7 activation Activation of the NLRc4 inflammasome was recently shown to restrict the intracellular replication of L. pneumophila, the causative agent of a severe form of bacte‑ rial pneumonia known as Legionnaires’ disease61,86,87. Inflammasome activation in resistant mouse strains results in the rapid caspase 1‑dependent delivery of L. pneumophila to lysosomes, where the bacteria are degraded. By contrast, defective inflammasome activa‑ tion in Nlrc4–/– and Casp1–/– mice allows bacterial repli‑ cation in specialized intracellular vesicles that resemble autophagosomes61,87. Notably, inflammasome‑mediated restriction of L. pneumophila replication proceeds independently of IL‑1β and IL‑18 (ReFs 61,87), but the caspase 1 substrates that are responsible for this proc‑ ess remain unclear. A proteome‑wide screen for new caspase 1 targets identified caspase 7, an effector caspase, as a direct substrate of caspase 1, and biochemical studies confirmed that caspase 7 is cleaved by caspase 1 after the canonical activation sites Asp23 and Asp198 (ReF. 51). Importantly, studies in macrophages from Nlrp3–/–, Nlrc4–/–, Asc–/– or Casp1–/– mice confirmed the role of %#4& Type III and type IV secretion %NGCXCIGQH 2#42CPF IN[EQN[UKUGP\[OGU %NGCXCIGQHCU [GVWPKFGPVKȮGF UWDUVTCVGU 2TQECURCUG %JCPIGUKPEGNNWNCT GPGTI[UQWTEGU /GODTCPG RGTOGCDKNK\CVKQP CPF&0# HTCIOGPVCVKQP %CURCUG 4GRCKTCPFJGCNKPI 2[TQRVQUKU 4GOQXCNQH KPVTCEGNNWNCT TGRNKECVKQPPKEJGU +OOWPG UWTXGKNNCPEG QHOKETQDKCN EQORQPGPVU 4GUVTKEVKQPQH .GIKQPGNNC TGRNKECVKQPD[ VCTIGVKPIVQ N[UQUQOGU Figure 3 | Caspase 1 effector mechanisms. Pathogen invasion of macrophages and dendritic cells triggers the assembly of inflammasome complexes and caspase 1 activation. Active caspase 1 induces inflammation by mediating the 0CVWTG4GXKGYU^+OOWPQNQI[ extracellular secretion or release of leaderless cytokines such as interleukin-1β (IL-1β), IL-18 and IL-1α, and possibly damage-associated molecular patterns (DAMPs) such as high mobility group box 1 (HMGB1), through an as yet unknown mechanism. Caspase 1 also promotes repair and healing responses by inducing lipid membrane biogenesis through the activation of sterol regulatory element binding proteins (SREBPs) and through the secretion or release of growth factors such as fibroblast growth factor 2. The latter contributes to repair through ligation of cell surface receptors on target cells. Caspase 1 cleaves poly(ADP-ribose) polymerase 1 (PARP1) and glycolysis enzymes, possibly to prepare host cells to undergo pyroptosis. This specialized cell death programme removes intracellular niches for microbial replication and eliminates infected immune cells. Moreover, it might help to tune immune responses by releasing microbial components into the extracellular milieu, where they can be detected by the immune system. It is probable that caspase 1 cleaves additional as yet unidentified substrates that are responsible for early membrane permeabilization and oligonucleosomal DNA fragmentation during pyroptosis. Finally, inflammasome-mediated activation of caspase 7 (an effector caspase) restricts bacterial replication in Legionella-infected macrophages by targeting the infectious agent to lysosomes. CARD, caspase recruitment domain. 218 | MARcH 2011 | voLuMe 11 www.nature.com/reviews/immunol © 2011 Macmillan Publishers Limited. All rights reserved REVIEWS whether inflammasome‑mediated activation of caspase 7 also restricts the replication of S. Typhimurium and other bacterial pathogens, and whether this inflammasome effector pathway is activated during viral infection. Conclusions and perspectives It has become evident in recent years that inflamma‑ somes have important roles in innate immune signalling and host defence. In particular, our knowledge of how inflammasome complexes of distinct composition are assembled in a stimulus‑dependent manner has grown significantly. Now, the different effector mechanisms (in addition to IL‑1β and IL‑18 secretion) by which inflam‑ masomes might contribute to immunity and host defence are also starting to emerge. As described above, recent studies have highlighted a range of new inflammasome functions and effector mechanisms (FIG. 3). caspase 1 has been shown to control the secretion of leaderless cytokines and proteins such as IL‑1α and FGF2, as well as the release of endogenous DAMPs such as HMGB1. Moreover, excessive caspase 1 activation in damaged neu‑ rons and infected myeloid cells induces pyroptotic cell death. Furthermore, caspase 1 dampens the metabolic rate of infected cells by cleaving key enzymes of the glyco‑ lysis pathway and regulates lipid metabolic pathways for cell repair. Finally, activation of the executioner caspase 7 downstream of inflammasomes contributes to restriction of Legionella replication in infected macrophages. Interestingly, most of these emerging functions of caspase 1 seem to operate independently of the canoni‑ cal substrates IL‑1β and IL‑18, and this indicates that inflammasomes contribute to innate immune responses in a variety of ways. Indeed, these effector mechanisms probably function together to mount a fast and effec‑ tive innate immune response against the pathogen and Villani, A. C. et al. Common variants in the NLRP3 region contribute to Crohn’s disease susceptibility. Nature Genet. 41, 71–76 (2009). 2. Zaki, M. H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379–391 (2010). 3. Allen, I. C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitisassociated cancer. J. Exp. Med. 207, 1045–1056 (2010). 4. Bauer, C. et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59, 1192–1199 (2010). 5. Dupaul-Chicoine, J. et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367–378 (2010). 6. Jin, Y. et al. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356, 1216–1225 (2007). 7. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006). 8. Magitta, N. F. et al. A coding polymorphism in NALP1 confers risk for autoimmune Addison’s disease and type 1 diabetes. Genes Immun. 10, 120–124 (2009). 9. Larsen, C. M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517–1526 (2007). 10. Agostini, L. et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder. Immunity 20, 319–325 (2004). 1. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. might instruct the adaptive immune system regarding the systemic risk posed by the invading microbial agent. At an early phase of infection, activation of caspase 7 downstream of the inflammasome might halt pathogen replication in intracellular replication niches, while at the same time inflammasome‑mediated activation of SReBPs could repair pathogen‑induced damage to the plasma membrane. when bacterial (or viral) loads fur‑ ther increase, inflammasomes can induce pyroptosis and instruct macrophages and dendritic cells to initi‑ ate the unconventional secretion or passive release of pro‑inflammatory cytokines, growth factors, DAMPs and microbial antigens to alert the immune system of an imminent threat and to initiate repair responses. In this context, the crucial role of pyroptosis in host defence was recently demonstrated in mice infected with the Gram‑negative bacterial pathogens L. pneumophila and B. thailandensis 34. Pyroptosis also confers resistance against Gram‑positive pathogens such as B. anthracis in vivo65, but its role in clearing viral and fungal infections remains to be determined. In addi‑ tion, much remains to be learned regarding exactly how caspase 1 induces pyroptosis and how inflammasomes regulate the unconventional secretion of leaderless pro‑ teins. what are the crucial components of the molecular machinery driving the secretion of leaderless proteins and how are they regulated by inflammasomes? Are unconventional protein secretion and pyroptosis intrin‑ sically linked or can they be uncoupled? what is the relative contribution of each of these inflammasome effector mechanisms to innate and adaptive immune responses during microbial infections? Answering these and other questions will undoubtedly illuminate intriguing new mechanisms by which inflammasomes contribute to host defence and immunity. Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A. & Kolodner, R. D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome. Nature Genet. 29, 301–305 (2001). Lamkanfi, M. & Dixit, V. M. The inflammasomes. PLoS Pathog. 5, e1000510 (2009). Kawai, T. & Akira, S. TLR signaling. Cell Death Differ. 13, 816–825 (2006). Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nature Rev. Immunol. 10, 210–215 (2010). Lamkanfi, M. & Dixit, V. M. Inflammasomes: guardians of cytosolic sanctity. Immunol. Rev. 227, 95–105 (2009). Gu, Y. et al. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275, 206–209 (1997). Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000–2003 (1995). Ghayur, T. et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386, 619–623 (1997). Li, P. et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80, 401–411 (1995). Joosten, L. A. et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1β. Arthritis Rheum. 60, 3651–3662 (2009). NATuRe RevIewS | Immunology 21. Irmler, M. et al. Granzyme A is an interleukin 1βconverting enzyme. J. Exp. Med. 181, 1917–1922 (1995). 22. Maelfait, J. et al. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1β maturation by caspase-8. J. Exp. Med. 205, 1967–1973 (2008). 23. Mayer-Barber, K. D. et al. Caspase-1 independent IL-1β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326–3330 (2010). 24. Kanneganti, T. D. Central roles of NLRs and inflammasomes in viral infection. Nature Rev. Immunol. 10, 688–698 (2010). 25. Sims, J. E. & Smith, D. E. The IL-1 family: regulators of immunity. Nature Rev. Immunol. 10, 89–102 (2010). 26. Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519–550 (2009). 27. Hoshino, T. et al. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J. Immunol. 166, 7014–7018 (2001). 28. Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423–474 (2001). 29. Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M. & Murphy, K. M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677–688 (2006). 30. Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol. 6, 1123–1132 (2005). voLuMe 11 | MARcH 2011 | 219 © 2011 Macmillan Publishers Limited. All rights reserved REVIEWS 31. Hoffman, H. M. et al. Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrinassociated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum. 58, 2443–2452 (2008). 32. Lachmann, H. J. et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N. Engl. J. Med. 360, 2416–2425 (2009). 33. Lamkanfi, M. et al. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 185, 4385–4392 (2010). This paper describes the role of the NLRP3 and NLRC4 inflammasomes in extracellular release of HMGB1. 34. Miao, E. A. et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nature Immunol. 11, 1136–1142 (2010). This paper describes the crucial role of caspase 1‑mediated cell death as a host defence mechanism against bacterial pathogens. 35. Henry, T. & Monack, D. M. Activation of the inflammasome upon Francisella tularensis infection: interplay of innate immune pathways and virulence factors. Cell. Microbiol. 9, 2543–2551 (2007). This paper describes the increased susceptibility of caspase 1‑deficient mice to infection with Francisella tularensis compared with mice lacking IL‑1β and IL‑18. 36. Trombetta, E. S. & Parodi, A. J. Quality control and protein folding in the secretory pathway. Annu. Rev. Cell. Dev. Biol. 19, 649–676 (2003). 37. Lee, M. C., Miller, E. A., Goldberg, J., Orci, L. & Schekman, R. Bi-directional protein transport between the ER and Golgi. Annu. Rev. Cell. Dev. Biol. 20, 87–123 (2004). 38. Nickel, W. & Rabouille, C. Mechanisms of regulated unconventional protein secretion. Nature Rev. Mol. Cell Biol. 10, 148–155 (2009). 39. Rubartelli, A., Cozzolino, F., Talio, M. & Sitia, R. A novel secretory pathway for interleukin-1β, a protein lacking a signal sequence. EMBO J. 9, 1503–1510 (1990). 40. Sutterwala, F. S. et al. Critical role for NALP3/CIAS1/ Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24, 317–327 (2006). 41. Keller, M., Ruegg, A., Werner, S. & Beer, H. D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818–831 (2008). This paper characterizes the role of caspase 1 in the secretion of IL‑1α and FGF2. 42. Becker, C. E., Creagh, E. M. & O’Neill, L. A. Rab39a binds caspase-1 and is required for caspase-1-dependent interleukin-1β secretion. J. Biol. Chem. 284, 34531–34537 (2009). 43. Salvesen, G. S. & Riedl, S. J. Caspase mechanisms. Adv. Exp. Med. Biol. 615, 13–23 (2008). 44. Riedl, S. J. & Shi, Y. Molecular mechanisms of caspase regulation during apoptosis. Nature Rev. Mol. Cell Biol. 5, 897–907 (2004). 45. Lamkanfi, M. & Dixit, V. M. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8, 44–54 (2010). 46. Strasser, A., O’Connor, L. & Dixit, V. M. Apoptosis signaling. Annu. Rev. Biochem. 69, 217–245 (2000). 47. Taylor, R. C., Cullen, S. P. & Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nature Rev. Mol. Cell Biol. 9, 231–241 (2008). 48. Kazama, H. et al. Induction of immunological tolerance by apoptotic cells requires caspasedependent oxidation of high-mobility group box-1 protein. Immunity 29, 21–32 (2008). 49. Savill, J., Dransfield, I., Gregory, C. & Haslett, C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nature Rev. Immunol. 2, 965–975 (2002). 50. Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213–218 (2004). 51. Lamkanfi, M. et al. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol. Cell. Proteomics 7, 2350–2363 (2008). This paper describes caspase 7 as a downstream effector of the NLRP3 and NLRC4 inflammasomes. 52. Fink, S. L. & Cookson, B. T. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell. Microbiol. 8, 1812–1825 (2006). 53. Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin/ Nalp3 inflammasome. J. Cell Biol. 187, 61–70 (2009). 54. Chen, Y., Smith, M. R., Thirumalai, K. & Zychlinsky, A. A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 15, 3853–3860 (1996). 55. Hilbi, H. et al. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 273, 32895–32900 (1998). 56. Monack, D. M., Detweiler, C. S. & Falkow, S. Salmonella pathogenicity island 2-dependent macrophage death is mediated in part by the host cysteine protease caspase-1. Cell. Microbiol. 3, 825–837 (2001). This paper reports that pyroptosis proceeds independently of IL‑1β and IL‑18. 57. van der Velden, A. W., Velasquez, M. & Starnbach, M. N. Salmonella rapidly kill dendritic cells via a caspase-1-dependent mechanism. J. Immunol. 171, 6742–6749 (2003). 58. Suzuki, T. et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog. 3, e111 (2007). 59. Miao, E. A. et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nature Immunol. 7, 569–575 (2006). 60. Franchi, L. et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nature Immunol. 7, 576–582 (2006). 61. Amer, A. et al. Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J. Biol. Chem. 281, 35217–35223 (2006). 62. Miao, E. A. et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl Acad. Sci. USA 107, 3076–3080 (2010). 63. Sutterwala, F. S. et al. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/ NLRC4 inflammasome. J. Exp. Med. 204, 3235–3245 (2007). 64. Boyden, E. D. & Dietrich, W. F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nature Genet. 38, 240–244 (2006). 65. Terra, J. K. et al. Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J. Immunol. 184, 17–20 (2010). 66. Munoz-Planillo, R., Franchi, L., Miller, L. S. & Nunez, G. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J. Immunol. 183, 3942–3948 (2009). 67. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228–232 (2006). 68. Sauer, J. D. et al. Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe 7, 412–419 (2010). 69. Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nature Immunol. 11, 385–393 (2010). 70. Rathinam, V. A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nature Immunol. 11, 395–402 (2010). 71. Jones, J. W. et al. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc. Natl Acad. Sci. USA 107, 9771–9776 (2010). 72. Wu, J., Fernandes-Alnemri, T. & Alnemri, E. S. Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes. J. Clin. Immunol. 30, 693–702 (2010). 73. Warren, S. E. et al. Cutting edge: cytosolic bacterial DNA activates the inflammasome via Aim2. J. Immunol. 185, 818–821 (2010). 74. Tsuchiya, K. et al. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J. Immunol. 185, 1186–1195 (2010). 75. Mariathasan, S., Weiss, D. S., Dixit, V. M. & Monack, D. M. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202, 1043–1049 (2005). 76. Monack, D. M., Raupach, B., Hromockyj, A. E. & Falkow, S. Salmonella typhimurium invasion induces 220 | MARcH 2011 | voLuMe 11 77. 78. 79. 80. 81. 82. 83. 84. 85. 86. 87. 88. 89. 90. 91. 92. 93. apoptosis in infected macrophages. Proc. Natl Acad. Sci. USA 93, 9833–9838 (1996). Fernandes-Alnemri, T. et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14, 1590–1604 (2007). Malireddi, R. K., Ippagunta, S., Lamkanfi, M. & Kanneganti, T. D. Cutting edge: proteolytic inactivation of poly(ADP-ribose) polymerase 1 by the Nlrp3 and Nlrc4 inflammasomes. J. Immunol. 185, 3127–3130 (2010). This paper describes the inflammasome‑dependent cleavage of PARP1 during pyroptosis. Akhter, A. et al. Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. PLoS Pathog. 5, e1000361 (2009). This paper describes the role of caspase 7 activation by the NLRC4 inflammasome in restricting Legionella replication. Lakhani, S. A. et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311, 847–851 (2006). Shao, W., Yeretssian, G., Doiron, K., Hussain, S. N. & Saleh, M. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282, 36321–36329 (2007). This paper describes glycolysis enzymes as substrates of caspase 1. Cramer, T. et al. HIF-1α is essential for myeloid cellmediated inflammation. Cell 112, 645–657 (2003). Gurcel, L., Abrami, L., Girardin, S., Tschopp, J. & van der Goot, F. G. Caspase-1 activation of lipid metabolic pathways in response to bacterial poreforming toxins promotes cell survival. Cell 126, 1135–1145 (2006). This paper reports that inflammasomes activate lipid metabolic pathways. Gonzalez, M. R., Bischofberger, M., Pernot, L., van der Goot, F. G. & Freche, B. Bacterial pore-forming toxins: the (w)hole story? Cell. Mol. Life Sci. 65, 493–507 (2008). McCoy, A. J. et al. Cytotoxins of the human pathogen Aeromonas hydrophila trigger, via the NLRP3 inflammasome, caspase-1 activation in macrophages. Eur. J. Immunol. 40, 2797–2803 (2010). Lamkanfi, M. et al. The Nod-like receptor family member Naip5/Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation. J. Immunol. 178, 8022–8027 (2007). Zamboni, D. S. et al. The Birc1e cytosolic patternrecognition receptor contributes to the detection and control of Legionella pneumophila infection. Nature Immunol. 7, 318–325 (2006). Broz, P. et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207, 1745–1755 (2010). Fischer, U., Janicke, R. U. & Schulze-Osthoff, K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10, 76–100 (2003). Lamkanfi, M., Festjens, N., Declercq, W., Vanden Berghe, T. & Vandenabeele, P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 14, 44–55 (2007). Boatright, K. M. et al. A unified model for apical caspase activation. Mol. Cell 11, 529–541 (2003). Martinon, F. & Tschopp, J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14, 10–22 (2007). Pizzirani, C. et al. Stimulation of P2 receptors causes release of IL-1β-loaded microvesicles from human dendritic cells. Blood 109, 3856–3864 (2007). Acknowledgements This work was supported by European Union Framework Program 7 (Marie Curie grant 256432) and by the Fund for Scientific Research – Flanders. Competing interests statement The author declares no competing financial interests. FURTHER INFORMATION Mohamed Lamkanfi’s homepage: http://www.vib.be/en/ research/scientists/Pages/Mohamed-Lamkanfi-Lab.aspx All lInks Are ACtIve In the onlIne pdf www.nature.com/reviews/immunol © 2011 Macmillan Publishers Limited. All rights reserved